Townsquare Capital LLC bought a new stake in shares of Encompass Health Co. (NYSE:EHC – Free Report) in the third quarter, HoldingsChannel.com reports. The firm bought 4,191 shares of the company’s stock, valued at approximately $405,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. QRG Capital Management Inc. grew its holdings in Encompass Health by 85.6% during the 2nd quarter. QRG Capital Management Inc. now owns 14,365 shares of the company’s stock valued at $1,232,000 after buying an additional 6,627 shares in the last quarter. SG Americas Securities LLC purchased a new stake in shares of Encompass Health during the 2nd quarter valued at about $2,204,000. Los Angeles Capital Management LLC lifted its stake in shares of Encompass Health by 532.4% in the 3rd quarter. Los Angeles Capital Management LLC now owns 50,290 shares of the company’s stock valued at $4,860,000 after purchasing an additional 42,338 shares during the last quarter. Pathstone Holdings LLC boosted its stake in Encompass Health by 54.5% during the third quarter. Pathstone Holdings LLC now owns 21,022 shares of the company’s stock worth $2,032,000 after buying an additional 7,412 shares during the period. Finally, Deerfield Management Company L.P. Series C purchased a new stake in shares of Encompass Health in the second quarter valued at $541,000. 97.25% of the stock is owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
Several research firms have recently weighed in on EHC. Barclays lifted their target price on Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. UBS Group boosted their price objective on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a research note on Wednesday, September 25th. Truist Financial reiterated a “buy” rating and issued a $116.00 target price (up from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. Royal Bank of Canada raised their price objective on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Finally, KeyCorp lifted their target price on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Nine analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, the stock has a consensus rating of “Buy” and an average price target of $107.11.
Encompass Health Trading Up 0.5 %
Shares of NYSE EHC opened at $102.87 on Friday. The company has a current ratio of 1.04, a quick ratio of 1.04 and a debt-to-equity ratio of 0.88. The stock has a market capitalization of $10.36 billion, a PE ratio of 24.85, a PEG ratio of 1.36 and a beta of 0.86. Encompass Health Co. has a twelve month low of $64.15 and a twelve month high of $104.55. The stock has a fifty day simple moving average of $98.61 and a 200-day simple moving average of $91.77.
Encompass Health (NYSE:EHC – Get Free Report) last posted its quarterly earnings data on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $0.94 by $0.09. Encompass Health had a return on equity of 17.60% and a net margin of 8.10%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter in the prior year, the company earned $0.86 earnings per share. The company’s revenue was up 11.9% on a year-over-year basis. On average, equities analysts forecast that Encompass Health Co. will post 4.29 earnings per share for the current year.
Encompass Health Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be given a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.66%. Encompass Health’s dividend payout ratio is presently 16.43%.
About Encompass Health
Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.
Featured Stories
- Five stocks we like better than Encompass Health
- 10 Best Airline Stocks to Buy
- NVIDIA’s Blackwell Chips Set for Arizona Manufacturing by TSMC?
- Consumer Staples Stocks, Explained
- Okta: Bullish Signals Suggest a Market Reversal Is Underway
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- BlackRock Makes Waves With $12B Private Credit Acquisition
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.